Who
Brian J. Brille
Director and Officer
Company insider
Files Form 4 as: Director and Officer, Caris Life Sciences.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 1
- Bought
- $630K
- Sold
- $24.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jun 2025
- Last trade
- 17 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $976K400,000 at $2.44 | filing |
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $12.1M400,000 at $30.33 | filing |
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —400,000 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —400,000 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $976K400,000 at $2.44 | filing |
| 17 Sep 2026filed 17 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $12.1M400,000 at $30.33 | filing |
| 15 May 2026filed 18 May 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $213K13,987 at $15.25 | filing |
| 15 May 2026filed 18 May 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $213K13,987 at $15.25 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —83,162 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —83,162 at $0.00 | filing |
| 11 Dec 2025filed 12 Dec 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code G | —650 at $0.00 | filing |
| 10 Dec 2025filed 12 Dec 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code G | —650 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Bought | $630K30,000 at $21.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —132,428 at $0.00 | filing |
News
Caris Life Sciences (NASDAQ:CAI) Stock Price Target Raised at JPMorgan Chase & Co.CAI · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Brian J. Brille; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.